Type 2 Diabetes Information Center

Updated guideline for oral pharmacologic treatment of type 2 diabetes

Updated guideline for oral pharmacologic treatment of type 2 diabetes

The ACP has updated the 2012 guideline to provide clinical recommendations of oral pharmacologic treatment of type 2 diabetes.

Healthday Sex hormone-binding globulin and estradiol associated with type 2 diabetes in women

Sex hormone-binding globulin and estradiol associated with type 2 diabetes in women

Women may have a higher risk of type 2 diabetes with low levels of sex hormone-binding globulin and high levels of total estradiol.

News Early intensification of diabetes therapy after metformin failure is beneficial

Early intensification of diabetes therapy after metformin failure is beneficial

Intensification of therapy within 6 months of metformin monotherapy failure resulted in rapid attainment of A1c goals.

News Oily fish consumption may lower diabetic retinopathy risk in type 2 diabetes

Oily fish consumption may lower diabetic retinopathy risk in type 2 diabetes

A target intake of at least 500 mg/d is recommended to combat sight-threatening diabetic retinopathy.

News Drug may slow renal disease progression in type 2 diabetes

Drug may slow renal disease progression in type 2 diabetes

Canagliflozin 100 mg or 300 mg slowed kidney decline compared with glimepiride.

Healthday Adlyxin approved for type 2 diabetes

Adlyxin approved for type 2 diabetes

The once-daily injection works to improve glycemic control.

Feature Cultural considerations in diabetes: controlling HbA1c in a patient observing Ramadan

Cultural considerations in diabetes: controlling HbA1c in a patient observing Ramadan

A patient with type 2 diabetes is undergoing dialysis and needs to control his HbA1c levels while fasting during Ramadan.

News New guidelines support use of metabolic surgery as standard treatment option for type 2 diabetes, obesity

New guidelines support use of metabolic surgery as standard treatment option for type 2 diabetes, obesity

A panel of experts has recommended that metabolic surgery be included as a treatment option for patients with type 2 diabetes and obesity.

News Metformin more effective than sulfonylureas for reducing cardiovascular mortality in diabetes patients

Metformin more effective than sulfonylureas for reducing cardiovascular mortality in diabetes patients

Compared with other drugs for type 2 diabetes, metformin is superior for reducing the risk of cardiovascular mortality.

News FDA issues warning for 2 diabetes drugs linked to risk of heart failure

FDA issues warning for 2 diabetes drugs linked to risk of heart failure

The FDA will add warnings about heart failure risk to the labels of type 2 diabetes medicines containing saxagliptin and alogliptin.

Sign Up for Free e-newsletters